[Federal Register Volume 65, Number 109 (Tuesday, June 6, 2000)]
[Notices]
[Pages 35937-35939]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-14097]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 00145]


Comprehensive Cancer Control; Notice of Availability of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2000 funds for a sole source 
cooperative agreement program for the enhancement and implementation of 
a comprehensive cancer control initiative. Comprehensive cancer control 
is an integrated and coordinated approach to reduce the incidence, 
morbidity, and mortality of cancer through prevention, early detection, 
treatment, rehabilitation, and palliation. This initiative addresses 
priority minority populations at the community level including 
medically underserved men and women.
    CDC is committed to achieving the health promotion and disease 
prevention objectives of ``Healthy People 2010,'' a national activity 
to reduce morbidity and mortality and improve the quality of life. This 
announcement is related to the focus area on cancer and the oral cancer 
objectives in Chapter 21, the oral health focus area. For the 
conference copy of ``Healthy People 2010,'' visit the Internet site 
http://www.health.gov/healthypeople.
    The purpose of the initiative is to assist with the following:
    <bullet> Enhanced coordination among those involved in all aspects 
of comprehensive cancer control, from prevention to palliation.
    <bullet> Implementation of priorities that support the State's 
comprehensive cancer control plan.
    <bullet> Increased cooperation and collaboration among risk-factor 
and cancer-specific programs and activities (including surveillance 
systems) without compromising the integrity of individual categorical 
programs.
    <bullet> Enhanced and strengthened coalitions and partnerships that 
support the overall goals and objectives of the comprehensive cancer 
control plan.
    <bullet> A coordinated approach to the dissemination of cancer-
related information; and education programs that are consumer-oriented 
and embody a comprehensive approach to cancer control.
    <bullet> Capacity-building and institutionalization of 
organizational changes promoting comprehensive and integrated cancer 
control.
    <bullet> The development or revision of a comprehensive cancer 
control plan that is being used to support the implementation of cancer 
prevention and control priorities.
    <bullet> Evaluation methods to track progress related to the 
planning and implementation of cancer control plan goals and 
objectives.

B. Eligible Applicants

    Assistance will be provided only to the University of Miami for its 
comprehensive South Florida Minority Cancer Initiative. No other 
applications are solicited. The sole source justification is based on 
congressional language in the Conference Report (H.R. Rep. 106-479, at 
601 (1999) to the Consolidated Appropriations Act, 2000 (Public Law 
106-113), which earmarked funding for the University of Miami, Miami, 
Florida.

    Note: Public Law 104-65 states that an organization described in 
section 501 (c)(4) of the Internal Revenue Code of 1986 that engages 
in lobbying activities is not eligible to receive Federal funds 
constituting an award, grant, cooperative agreement, contract, loan, 
or any other form.

C. Availability of Funds

    Approximately $800,000 is available in FY 2000 to fund the program 
described below. It is expected that the awards will begin September 
30, 2000, and will be made for a 12-month budget period within a 
project period of up to 3 years. Funding estimates may change.
    Continuation awards within an approved project period will be made 
on the basis of satisfactory progress as evidenced by required reports 
and the availability of funds.

Use of Funds

    Cooperative agreement funds may not be expended to provide 
inpatient hospital or treatment services. Treatment is defined as any 
service recommended by a clinician, including medical and surgical 
intervention provided in the management of a diagnosed condition.
    These funds are intended for comprehensive cancer control and 
should not be used to directly support other existing programs such as 
breast and cervical cancer programs, cancer registry programs, 
laboratory or clinical services, or tobacco control programs. 
Indirectly, these funds may be used to assist with the integration and 
coordination of activities related to these existing programs. Thus, 
these funds should be used to assist with the coordination of these and 
other categorical programs into comprehensive cancer control 
activities. Funds awarded under this program announcement may not be 
used to supplant existing program efforts.

D. Program Requirements

    Comprehensive cancer control activities should adhere to current 
accepted public health recommendations by the U.S. Preventive Services 
Task Force, or current Division of Cancer Prevention and Control (DCPC) 
guidance.
    In conducting activities to achieve the purpose of the program, the 
recipient shall be responsible for the following activities under 1. 
(Recipient Activities), and CDC will be responsible for activities 
listed under 2. (CDC Activities).

1. Recipient Activities

    a. Identify and hire necessary key staff to implement the 
comprehensive cancer control plan.
    b. Maintain or enhance a broad-based comprehensive cancer control 
coalition that includes representation from throughout the state. This 
coalition should include key private, professional, voluntary, and 
nonprofit organizations, policymakers, consumers

[[Page 35938]]

(including cancer survivors), payers, media, State and federal 
agencies, research and academic institutions, schools, etc. Particular 
emphasis should be placed on ensuring participation from organizations 
representing minority and medically underserved populations.
    c. Establish and implement priorities that support the State's 
comprehensive cancer control plan, which provides a framework for 
planning and action to reduce the burden of cancer in the State. 
Implementation should be guided by goals and objectives documented in 
an implementation plan to be developed or included as part of this 
application.
    d. Promote collaboration and coordination among existing state-
based surveillance systems for use in monitoring changes in cancer 
disease burden and programmatic impact of the comprehensive cancer 
control efforts especially in minority and medically underserved 
populations. Data should be used for program modifications and 
improvements, evaluation, and updating the comprehensive cancer control 
plan, as appropriate.
    e. Evaluate progress and impact of the program based on a 
systematic evaluation plan. In addition to evaluating progress in 
meeting goals, process and impact objectives of the implementation 
plan, the program should develop performance indicators to use as 
benchmarks for improvement and to determine the success of the overall 
comprehensive cancer control effort.
    f. Promote the development and dissemination of information and 
education programs that will contribute to comprehensive cancer 
control; and as appropriate, participate in national cancer prevention, 
early detection, and control campaigns. Program should use existing 
education resources as well as develop materials and activities that 
address specific needs of the minority and medically underserved 
populations, as necessary and appropriate. School health education and 
policies should be considered as part of these strategies. In addition 
to addressing educational needs of the targeted populations, programs 
should also consider activities that attempt to make individual, 
policy, organizational or environmental interventions and changes that 
can encourage primary prevention at all levels, e.g., organizational 
changes that can reinforce and support individual behavior changes.
    g. Participate in CDC-sponsored trainings, meetings, site visits, 
and conferences.

2. CDC Activities

    a. Convene meetings for information-sharing or training. As 
appropriate, these meetings will be conducted with other CDC 
comprehensive cancer control cooperative agreement recipients.
    b. Facilitate the exchange of information and collaboration between 
the recipient and other local, state, regional or national 
comprehensive cancer control efforts.
    c. Disseminate to recipient relevant state-of-the-art research 
findings and public health recommendations related to comprehensive 
cancer control.
    d. Provide ongoing guidance, consultation, and technical assistance 
in conducting Recipient Activities.
    e. Conduct site visits to assess program progress, and mutually 
resolve problems, as needed, and coordinate reverse site visits to CDC 
in Atlanta, Georgia.

F. Application Content

    Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Your application will be evaluated on the criteria 
listed, so it is important to follow them in laying out your program 
plan. The narrative should be no more than 20 (twenty) double-spaced 
pages, printed on one side, with one-inch margins, and unreduced 12 
point font.

1. Statement of Need

    Identify opportunities for enhancement/improvement and existing 
gaps in the support of comprehensive cancer control and prevention 
activities. Describe the extent to which the proposed program will fill 
existing gaps and provide a brief description of each programmatic plan 
or research activity.

2. Objectives

    Establish and submit short- and long-term objectives relative to 
the described need in Section 1 above. Objectives must be specific, 
measurable, attainable, time phased, and realistic.

3. Operational Plan

    Submit an operational plan including a timeline that addresses the 
means for achieving each of the objectives established in Section 2 
(objectives) above. Provide a concise description of each component or 
major activity and how it will be implemented. The plan must identify 
and establish a time line for the completion of each component or major 
activity.

4. Evaluation Plan

    Submit a plan for monitoring progress toward achieving each of the 
objectives stated in Section 2 (objectives) above.

5. Program Management

    Describe the organizational capacity to conduct and manage cancer 
prevention and control projects and the project need, functions, and 
qualification for each program or research personnel requested.

6. Budget

    Submit a detailed budget and narrative justification that is 
consistent with the purpose of the program and the proposed activities.

F. Submission and Deadline

    Submit the original and two copies of PHS 5161-1 (OMB Number 0937-
0189).
    On or before August 1, 2000, submit the application to the Grants 
Management Specialist identified in the ``Where to Obtain Additional 
Information'' section of this announcement.
    Deadline: Applications will be considered as meeting the deadline 
if they are either:
    a. Received on or before the stated deadline date; or
    b. Sent on or before the deadline date. (Applicants must request a 
legibly dated U.S. Postal Service postmark or obtain a legibly dated 
receipt from a commercial carrier or the U.S. Postal Service. Private 
metered postmarks shall not be acceptable proof of timely mailing.)
    Late Applications: Applications which do not meet the criteria in 
a. or b. above are considered late applications and will be returned to 
the applicant.

G. Evaluation Criteria

    The application will be evaluated according to the following 
criteria by an independent review group appointed by CDC.
    1. Need statement. The extent to which the applicant identifies 
specific opportunities and existing gaps related to the purpose of the 
program. (10 points)
    2. Objectives. The degree to which short- and long-term objectives 
are specific, measurable, attainable, time phased, and realistic. (20 
points)
    3. Operational Plans. The adequacy of the applicant's plan to carry 
out the proposed activities, including the extent to which the 
applicant plans to work collaboratively with other organizations and 
individuals who may have an impact on cancer prevention and control 
objectives particularly among minority and medically underserved

[[Page 35939]]

populations; and the extent to which the proposal timeline appears 
feasible. (25 points)
    4. Evaluation Plan. The extent to which the evaluation plan appears 
capable of monitoring progress toward meeting project objectives. (25 
points)
    5. Program Management. The extent to which applicant demonstrates 
the ability to conduct and manage cancer prevention and control 
projects and that proposed staff appear to be qualified and possess 
capacity to perform the project. (20 points)
    6. Budget. The extent to which each line-item budget and narrative 
justification are reasonable and consistent with the purpose and 
objectives of the program. (Not scored)
    7. Human Subjects. Does the application adequately address the 
requirements of Title 45 CFR Part 46 for the protection of human 
subjects? (Not scored)
    The degree to which the applicant has met the CDC Policy 
requirements regarding the inclusion of women, ethnic, and racial 
groups in the proposed research. This includes--
    a. The proposed plan for the inclusion of both sexes and racial and 
ethnic minority populations for appropriate representation.
    b. The proposed justification when representation is limited or 
absent.
    c. A statement as to whether the design of the study is adequate to 
measure differences when warranted.
    d. A statement as to whether the plans for recruitment and research 
for study participants include the process of establishing partnerships 
with community(ies) and recognition of mutual benefits.

H. Other Requirements

Technical Reporting Requirements

    Provide CDC with the original plus two copies of the following:
    1. Annual written progress report must be submitted 30 days after 
the end of each budget period.
    2. Financial status report (FSR) must be submitted 90 days after 
the end of each budget period.
    3. Final financial and performance reports, must be submitted 90 
days after the end of the project period.
    Send all reports to the Grants Management Specialist identified in 
the ``Where to Obtain Additional Information'' section of this 
announcement.
    The following additional requirements are applicable to this 
program. For a complete description of each, see Attachment I in the 
application package.

AR-1  Human Subjects Requirement
AR-2  Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-9  Paperwork Reduction Act Requirements
AR-10  Smoke-Free Workplace Requirements
AR-11  Healthy People 2010
AR-12  Lobbying Restrictions
AR-20  Conference Support

I. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under sections 301(a), 317(k)(2) of the 
Public Health Service Act [42 U.S.C. 241(a) and 247b(k)(2)], as 
amended. The Catalog of Federal Domestic Assistance Number for this 
program is 93.283.

J. Where To Obtain Additional Information

    For this announcement and other CDC program announcements see the 
CDC home page on the Internet: http://www.cdc.gov.
    If you have questions after reviewing the contents of all the 
documents, business management technical assistance may be obtained 
from: Cynthia Collins, Grants Management Specialist, Grants Management 
Branch, Procurement and Grants Office, Announcement 00145, Centers for 
Disease Control and Prevention (CDC), Room 3627, 2920 Brandywine Road, 
Atlanta, GA 30341, Telephone (770) 488-2757, E-mail address 
<a href="/cdn-cgi/l/email-protection#91f2f2fefdfdf8ffe2d1f2f5f2bff6fee7"><span class="__cf_email__" data-cfemail="3b58585457575255487b585f58155c544d">[email protected]</span></a>.
    For program technical assistance, contact: Corinne Graffunder, 
Chief, Section A, Program Services Branch, Division of Cancer 
Prevention and Control, National Center for Chronic Disease Prevention 
and Health Promotion, Centers for Disease Control and Prevention (CDC), 
4770 Buford Highway NE., Mailstop K-57, Atlanta, GA 30341-3724, 
Telephone (770) 488-4880, fax (770) 488-3230. E-mail address: 
<a href="/cdn-cgi/l/email-protection#53303421323535263d373621133037307d343c25"><span class="__cf_email__" data-cfemail="7714100516111102191312053714131459101801">[email protected]</span></a>.

    Dated: May 31, 2000.
John L. Williams,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 00-14097 Filed 6-5-00; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>